At a nurse practitioner-owned and operated clinic, researchers performed continuous PDSA cycles of quality improvement to ...

Even with all the advances in technology, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, said patients ...

The updated guidelines recommend SGLT2 inhibitors as first-line therapy for many cats with diabetes and detail patient selection, β-hydroxybutyrate monitoring, diet, and when to switch to insulin. "My ...

Delhi Health Minister Pankaj Kumar Singh on Tuesday launched the Stop Diarrhoea Campaign 2026, virtually inaugurated a Model ...

MiniMed automated insulin delivery and smart MDI systems can now be paired with Instinct and Instinct Go, made by Abbott, the smallest, longest-wear sensors in the company's portfolioNORTHRIDGE ...

Mounjaro. It costs me £300 (€350) a month, but it quelled my eating disorder and reversed my pre-diabetes. Is not having ...

Share on Pinterest The first-ever CKM guideline reframes obesity as a key metabolic factor. Image credit: Photo by Halfpoint Images/Getty Images Updated guidance now frames obesity as a central driver ...

Some of the most pressing health conditions — including heart disease, kidney disease and diabetes — are best managed as a whole, according to a new clinical guideline. Published June 9 in Circulation ...

The first guideline for cardiovascular-kidney-metabolic syndrome (CKM syndrome), published today by American Heart Association and the American College of Cardiology, identifies obesity as a key ...

In an era dominated by social media, misinformation has become an all too familiar foe, infiltrating our feeds and sowing seeds of doubt and confusion. With more than half of social media users across ...

Development used MEDLINE 2017–2023 plus meta-analyses to 2025; recommendations required ≥80% external reviewers scoring ≥7/9, incorporating patient representatives. First-line for uncomplicated ...

Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials Clinical ...